# Prime Medicine, Inc. (PRME)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PRME/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.01M | $ -91.23M | $ -84.02M | $ 112.48M | $ 39.81M |
| 2025 | $ 4.74M | $ -205.95M | $ -171.09M | $ 116.43M | $ 120.87M |
| 2024 | $ 3.14M | $ -205.89M | $ -136.81M | $ 40.79M | $ 153.15M |
| 2023 | $ 0 | $ -214.23M | $ -188.29M | $ 13.63M | $ 133.07M |
| 2022 | $ 0 | $ -143.19M | $ -165.24M | $ 28.75M | $ 316.27M |
| 2021 | $ 0 | $ -196.56M | $ -45.44M | $ 10.41M | $ 239.56M |
| 2020 | $ 0 | $ -3.27M | $ -3.54M | N/A | N/A |
| 2019 | $ 0 | $ -3.26M | $ -1.72M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.83 |
| Liabilities / Eq | 5.26 |
| Current Ratio | 3.05 |

## Other views

- [Metrics](https://sponda.capital/en/PRME.md)
- [Charts](https://sponda.capital/en/PRME/charts.md)
- [Compare](https://sponda.capital/en/PRME/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.
